DK0790994T3 - Heterocyclisk substituerede propensyrederivater som NMDA-antagonister - Google Patents

Heterocyclisk substituerede propensyrederivater som NMDA-antagonister

Info

Publication number
DK0790994T3
DK0790994T3 DK95933902T DK95933902T DK0790994T3 DK 0790994 T3 DK0790994 T3 DK 0790994T3 DK 95933902 T DK95933902 T DK 95933902T DK 95933902 T DK95933902 T DK 95933902T DK 0790994 T3 DK0790994 T3 DK 0790994T3
Authority
DK
Denmark
Prior art keywords
acid derivatives
propenoic acid
nmda antagonists
heterocyclic substituted
substituted propenoic
Prior art date
Application number
DK95933902T
Other languages
Danish (da)
English (en)
Inventor
Robert A Farr
Boyd L Harrison
Philip L Nyce
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0790994T3 publication Critical patent/DK0790994T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK95933902T 1994-10-31 1995-09-21 Heterocyclisk substituerede propensyrederivater som NMDA-antagonister DK0790994T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08332016 US5563157B1 (en) 1994-10-31 1994-10-31 Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
PCT/US1995/012085 WO1996013501A1 (en) 1994-10-31 1995-09-21 Heterocycle substituted propenoic acid derivatives as nmda antagonists

Publications (1)

Publication Number Publication Date
DK0790994T3 true DK0790994T3 (da) 2002-08-26

Family

ID=23296353

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95933902T DK0790994T3 (da) 1994-10-31 1995-09-21 Heterocyclisk substituerede propensyrederivater som NMDA-antagonister

Country Status (21)

Country Link
US (3) US5563157B1 (de)
EP (1) EP0790994B1 (de)
JP (1) JP3934678B2 (de)
KR (1) KR100401138B1 (de)
CN (1) CN1068001C (de)
AT (1) ATE217307T1 (de)
AU (1) AU696423B2 (de)
CA (1) CA2202992C (de)
DE (1) DE69526668T2 (de)
DK (1) DK0790994T3 (de)
ES (1) ES2173198T3 (de)
FI (1) FI971831A0 (de)
HU (1) HU222372B1 (de)
IL (1) IL115791A (de)
MX (1) MX9703146A (de)
NO (1) NO313197B1 (de)
NZ (1) NZ293842A (de)
PT (1) PT790994E (de)
TW (1) TW336232B (de)
WO (1) WO1996013501A1 (de)
ZA (1) ZA959046B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
GB9902455D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
JP2004529855A (ja) 2000-10-10 2004-09-30 スミスクライン ビーチャム コーポレーション 置換インドール類、そのような置換インドール類を含む医薬組成物及びPPAR−γ結合剤としてのそれらの使用
US7375136B2 (en) * 2001-03-08 2008-05-20 Emory University pH-dependent NMDA receptor antagonists
KR20100045983A (ko) 2007-06-29 2010-05-04 에모리 유니버시티 신경보호를 위한 nmda 수용체 길항물질

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2088011T3 (es) * 1990-07-16 1996-08-01 Merrell Pharma Inc Antagonistas de aminoacidos excitadores.
ES2103832T3 (es) * 1990-10-15 1997-10-01 Astra Ab Derivados de 2-fenil y 2-tienil-(2)-piperidina que tienen propiedades neuroprotectoras.
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
WO1994027964A1 (en) * 1993-05-27 1994-12-08 Merrell Dow Pharmaceuticals Inc. 3-(indol-3-yl) propenoic acid derivatives and as nmda antagonists

Also Published As

Publication number Publication date
HUT77174A (hu) 1998-03-02
IL115791A0 (en) 1996-01-19
DE69526668T2 (de) 2003-01-02
US5563157A (en) 1996-10-08
ATE217307T1 (de) 2002-05-15
AU696423B2 (en) 1998-09-10
FI971831A (fi) 1997-04-29
IL115791A (en) 2000-09-28
JP3934678B2 (ja) 2007-06-20
MX9703146A (es) 1997-06-28
NO971991L (no) 1997-04-29
ZA959046B (en) 1996-05-17
AU3638795A (en) 1996-05-23
CN1068001C (zh) 2001-07-04
DE69526668D1 (de) 2002-06-13
EP0790994A1 (de) 1997-08-27
NZ293842A (en) 1998-09-24
TW336232B (en) 1998-07-11
CA2202992C (en) 2003-05-13
KR100401138B1 (ko) 2003-12-24
CA2202992A1 (en) 1996-05-09
ES2173198T3 (es) 2002-10-16
PT790994E (pt) 2002-08-30
JPH10508019A (ja) 1998-08-04
NO971991D0 (no) 1997-04-29
US5981553A (en) 1999-11-09
CN1161696A (zh) 1997-10-08
US6180786B1 (en) 2001-01-30
US5563157B1 (en) 1999-02-02
EP0790994B1 (de) 2002-05-08
WO1996013501A1 (en) 1996-05-09
HU222372B1 (hu) 2003-06-28
FI971831A0 (fi) 1997-04-29
NO313197B1 (no) 2002-08-26

Similar Documents

Publication Publication Date Title
DK0891325T3 (da) Para-substituerede phenylpropansyrederivater som integrinantagonister
PT1007523E (pt) Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
PT1193270E (pt) Pirrolobenzodiazepinas
YU104690A (sh) Supstituisani imidazo-kondenzovani 6-člani heterocikli kao antagonisti angiotenzina 2
DK0889876T3 (da) Meta-substituerede phenylensulfonamidderivater
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
EE03869B1 (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
TR200000737T2 (tr) İkame edilmiş kroman türevleri.
DK0696194T3 (da) Anvendelse af indolderivater som 5HT1-antagonister
CY1106376T1 (el) Δικυκλικα παραγωγα των αμινο-πυραζινονων, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα πepιεχουν
NO963331L (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
ID22838A (id) Oksazolidina sebagai antagonis 5-ht2a
ATE375985T1 (de) Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten
NO20014855D0 (no) N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
DK0790994T3 (da) Heterocyclisk substituerede propensyrederivater som NMDA-antagonister
FI941136A0 (fi) Kamferin piperatsinyyli(sulfonyyli)amidijohdannaiset oksitosiiniantagonisteina
HUP0000882A2 (hu) NMDA (N-metil-D-aszpartát) antagonista hatású indolszármazékok, valamint a vegyületeket tartalmazó gyógyszerkészítmények
SE9902387D0 (sv) New pharmaceutically active compounds
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
DE69526738D1 (de) Endothelin-rezeptor-antagonisten
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
SE9800835D0 (sv) New Compounds
NO20004075L (no) Substituerte pyrimidin-2-yloksy-karboksylsyrederivater, fremstilling av disse og deres anvendelse som endotelin- antagonister